Zobrazeno 1 - 10 of 40 pro vyhledávání: '"Su Jun Gao"'
1
Akademický článek
Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study
Autor: Zheng-Li Xu, Lan-Ping Xu, De-Pei Wu, Shun-Qing Wang, Xi Zhang, Rui Xi, Su-Jun Gao, Ling-Hui Xia, Jian-Min Yang, Ming Jiang, Xin Wang, Qi-Fa Liu, Jia Chen, Ming Zhou, Xiao-Jun Huang
Publikováno v: Haematologica, Vol 107, Iss 12 (2022)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curative option for severe aplastic anemia (SAA), and transplantation from identical sibling donors (ISD) has been recommended as a first-line treatment. Haploidentical donor (H
Externí odkaz: https://doaj.org/article/b32cd12f96dd495c9a95be3032d97948
Zobrazit plný text záznamu
2
Akademický článek
Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
Autor: Long Su, Yuan-Yuan Shi, Zeng-Yan Liu, Su-Jun Gao
Publikováno v: Frontiers in Oncology, Vol 12 (2022)
Mutations in CCAAT enhancer binding protein A gene (CEBPA) are one of the common genetic alterations in acute myeloid leukemia (AML). Recently, the emergence of new evidence makes it necessary to reconsider the subsets and treatment of AML patients w
Externí odkaz: https://doaj.org/article/3e34608a1c4c46e1b206a78d815c8a2a
Zobrazit plný text záznamu
3
Akademický článek
Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia
Autor: Qiu-Sha Huang, Jing-Zhi Wang, Ya-Zhen Qin, Qiao-Zhu Zeng, Qian Jiang, Hao Jiang, Jin Lu, Hui-Xin Liu, Yi Liu, Jing-Bo Wang, Li Su, Hong-Yu Zhang, Zhen-Ling Li, Su-Jun Gao, Bo Huang, Yu-Ying Liu, Yan-Rong Liu, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang
Publikováno v: Blood Advances, Vol 3, Iss 21, Pp 3406-3418 (2019)
Abstract: Thrombocytopenia is associated with life-threatening bleeding and is common in myelodysplastic syndromes (MDS). Robust molecular prognostic biomarkers need to be developed to improve clinical decision making for patients with MDS with throm
Externí odkaz: https://doaj.org/article/72e7652bfee943deb8dba07ee880977b
Zobrazit plný text záznamu
4
Akademický článek
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
Autor: Lan-Ping Xu, Shun-Qing Wang, Yan-Ru Ma, Su-Jun Gao, Yi-Fei Cheng, Yuan-Yuan Zhang, Wen-Jian Mo, Xiao-Dong Mo, Yu-Ping Zhang, Chen-Hua Yan, Yu-Hong Chen, Ming Zhou, Yu Wang, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Publikováno v: Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background Haploidentical transplantation has been proposed as an effective treatment for severe aplastic anemia (SAA). The majority of patients have more than one HLA-haploidentical donor. Herein, we compared the outcomes between different
Externí odkaz: https://doaj.org/article/21462ae908c8435b98eae7fa9f232b85
Zobrazit plný text záznamu
5
Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia
Autor: Yun-wei Zhang, Long Su, Ye-hui Tan, Hai Lin, Xiao-liang Liu, Qiu-ju Liu, Jing-nan Sun, Ming Zhang, Ya-zhe Du, Fei Song, Wei Han, Su-jun Gao
Publikováno v: Annals of Hematology. 102:337-347
Acute myeloid leukemia (AML) with NPM1 mutation is a distinct genetic entity with favorable outcomes. Nevertheless, emerging evidence suggests that NPM1-mutated AML is still a highly heterogeneous disorder. In this study, 266 patients with AML with N
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cb773775819c4866016ee49145d7da
https://doi.org/10.1007/s00277-022-05033-0
Zobrazit plný text záznamu
6
Akademický článek
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
Autor: Lan-Ping Xu, Song Jin, Shun-Qing Wang, Ling-Hui Xia, Hai Bai, Su-Jun Gao, Qi-Fa Liu, Jian-Min Wang, Xin Wang, Ming Jiang, Xi Zhang, De-Pei Wu, Xiao-Jun Huang
Publikováno v: Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Abstract Background Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable identical donors and those who are refractory to immunosuppres
Externí odkaz: https://doaj.org/article/dcef0791e73246cbb981fadf7d6eb50b
Zobrazit plný text záznamu
9
Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective study
Autor: Lan-Ping, Xu, Zheng-Li, Xu, Shun-Qing, Wang, De-Pei, Wu, Su-Jun, Gao, Jian-Min, Yang, Ling-Hui, Xia, Qi-Fa, Liu, Ming, Jiang, Hai, Bai, Xi, Zhang, Xin, Wang, Xiao-Jun, Huang
Publikováno v: Science Bulletin. 67:963-970
In recent decades, haploidentical stem cell transplantation (haplo-SCT) to treat severe aplastic anemia (SAA) has achieved remarkable progress. However, long-term results are still lacking. We conducted a multicenter prospective study involving SAA p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b88fcfa60014926f1b3d411dcb39917
https://doi.org/10.1016/j.scib.2022.01.024
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje